• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Sobi starts rolling FDA filing for chronic gout drug

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 02, 2024 at 11:22: AM
via Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to current treatments.

article source
 




Top Bottom
Back
Quote